Investors Purchase Large Volume of Tempus AI Call Options (NASDAQ:TEM)

Tempus AI, Inc. (NASDAQ:TEM) was the recipient of unusually large options trading activity on Friday. Stock investors bought 89,671 call options on the stock. Thisrepresentsanincreaseof63% compared to the average volume of 54,925 call options.

Insider Transactions at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 5,000 shares of the business’s stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $60.00, for a total value of $300,000.00. Following the sale, the chief operating officer directly owned 145,000 shares in the company, valued at approximately $8,700,000. The trade was a 3.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Erik Phelps sold 51,317 shares of the business’s stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the completion of the sale, the executive vice president owned 97,779 shares in the company, valued at approximately $7,094,844.24. This trade represents a 34.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 758,772 shares of company stock valued at $51,005,175 in the last quarter. 27.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Tempus AI

Several institutional investors have recently made changes to their positions in the company. ARK Investment Management LLC lifted its holdings in shares of Tempus AI by 35.9% during the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after buying an additional 1,981,755 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock valued at $289,204,000 after buying an additional 5,900,668 shares during the last quarter. Nikko Asset Management Americas Inc. lifted its holdings in shares of Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock valued at $205,401,000 after buying an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after buying an additional 1,016,384 shares during the last quarter. Finally, Frontier Capital Management Co. LLC lifted its holdings in shares of Tempus AI by 236.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 943,718 shares of the company’s stock valued at $31,860,000 after buying an additional 663,018 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Trading Up 3.6%

NASDAQ:TEM opened at $60.87 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56. Tempus AI has a fifty-two week low of $31.36 and a fifty-two week high of $91.45. The stock’s 50-day moving average is $62.47 and its two-hundred day moving average is $58.00. The stock has a market cap of $10.54 billion, a PE ratio of -7.80 and a beta of 4.98.

Tempus AI (NASDAQ:TEM) last released its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The company had revenue of $314.64 million for the quarter, compared to analysts’ expectations of $296.84 million. During the same quarter in the previous year, the business posted ($6.86) EPS. The business’s revenue for the quarter was up 89.5% on a year-over-year basis. As a group, equities research analysts forecast that Tempus AI will post -6.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on TEM. Bank of America lifted their price target on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 25th. Piper Sandler reissued a “neutral” rating on shares of Tempus AI in a research note on Friday. Guggenheim lifted their price target on Tempus AI from $65.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. Needham & Company LLC reissued a “buy” rating and issued a $70.00 price target on shares of Tempus AI in a research note on Friday. Finally, BTIG Research began coverage on Tempus AI in a research note on Friday. They issued a “buy” rating and a $60.00 price target on the stock. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Tempus AI presently has an average rating of “Moderate Buy” and an average target price of $65.09.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.